Genre StrategyReleased Feb 18, 2016

Plague Inc: Evolved

Developed and published by Ndemic Creations
Estimated lifetime revenue
$5.17M
Gross, before Steam's cut
Net revenue
$3.62M
After Steam's 30% cut
Units sold
660.2K
≈ 10 sales per review
Confidence
High
Based on 66,342 reviews
How we estimate →
Reviews
66,342
Very Positive94% positive
Playing now
556
13-day peak 1,137 · low 449
New reviews, last 13 days
+340
≈ 26 a day since Oct 1

History

Oct 1 – Oct 14

66.4K66.2K66.1K66.0K
Oct 1Oct 7Oct 14

Total Steam reviews. The slope is the signal: a steady climb long after launch means the game is still selling.

How it compares

Strategy →

Against the 120 most-reviewed Strategy games on Steam

Outearns 31% of them — below the group's median.

Median
$15.59M
114,721 reviews
Top 10% start at
$67.69M
This game
$5.17M
23rd pct. by reviews

The group is the games with the most reviews under this tag, not every release, so it leans toward games that sold — a percentile here is a harder test than the same percentile across the whole store would be.

About

Plague Inc: Evolved is a unique mix of high strategy and terrifyingly realistic simulation. Your pathogen has just infected 'Patient Zero' - now you must bring about the end of human history by evolving a deadly, global Plague whilst adapting against everything humanity can do to defend itself.

Developer
Ndemic Creations
Publisher
Ndemic Creations
Genre
Strategy
Released
Feb 18, 2016
Steam app ID
246620
Data updated
Oct 14, 2026
Estimates, not reported sales. No developer-published figures are on file for this game. See the methodology for how the numbers are built.